학술논문
Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertion mutations who progressed after platinum-based chemotherapy
Document Type
Article
Author
Source
In Lung Cancer June 2022 168:74-82
Subject
Language
ISSN
0169-5002